Boston Taiwanese Biotechnology Association
Boston Taiwanese Biotechnology Association (BTBA) is a non-profit organization started in 2012 by a group of Taiwanese graduate students, postdocs and young professionals in the greater Boston area. Our goals are to foster individual career development, to enhance scientific collaborations, to facilitate interactions and to strengthen networking among academic and industrial bioscience communities in Taiwan and US.
Event
Career Development Series
Drug Delivery—the current development and future
Register here
Meet People, Catch Up With Friends, And Learn
Career Development Series
The Stories Post Approval
Register here
Career Development Series
The Role of Human Genetics in Understanding Cognitive Function and Neurodegenerative Diseases.
Podcast
S4 EP.11：「商業與策略」系列 - 藥廠投資組合管理 ft. 羅盈智醫師 (Dr. Ying-Chih (Paul) Lo) 🎧
Apr 02, 2024
新藥開發是一條充滿荊棘的道路，除了漫長的開發時間之外，人力和資金的投入也非常驚人，更令人頭痛的是，新藥開發的失敗率相當高，風險極大。在這樣一個複雜的產業裡，如果沒有辦法時刻抓住市場動態、做好資源 ...More info
S4 EP.10：腦與神經科學系列：腦機介面的現實與未來 ft. 徐聖修博士（Dr. Sheng-Hsiou (Shawn) Hsu）(2/2) 🎧
Mar 15, 2024
最近 Elon Musk 的 Neuralink 據稱開始人體試驗，Neuralink 嘗試將人腦與大腦連結。但你知道嗎，Neuralink其實並不是第一個做人體試驗的腦機介面公司。而且腦機介面 ...More info
S4 EP.9：腦與神經科學系列：腦機介面的現實與未來 ft. 徐聖修博士（Dr. Sheng-Hsiou (Shawn) Hsu）(1/2) 🎧
Mar 01, 2024
最近 Elon Musk 的 Neuralink 據稱開始人體試驗，Neuralink 嘗試將人腦與電腦連結，將《駭客任務 (The Matrix)》成為現實的決心，引發各界許多關於腦機介面的討 ...More info
Blog
藥廠投資組合管理．羅盈智醫師 (Dr. Ying-Chih (Paul) Lo)．訪談摘要
By 文：林書弘．圖：陳政儀．編輯：劉駿 on Apr, 2024
在現今的生技產業中，投資組合管理與數據分析技術的重要性日益增加。尤其在藥物開發這一高風險領域，有效的策略和先進的技術可以顯著提升研發的成功率及市場競爭力。透過近期與羅盈智醫師（Paul）的對話，我們得以深入了解這些策略如何在實際應用中發揮作用。 Paul目前在美國波士頓的 Novartis 藥廠擔任 Portfolio Data Science 部門的副總監，同時也是波士頓台灣醫師協會的會長。他的職業生涯跨越了醫療、人工智慧和商業策略，這使他對於藥廠如何進行投資組合管理有著獨到的見解。 ...Read more
Po-Jen (Will) Yen, Business Development
By Yi-Shan Chen on Mar, 2019
As a scientist in Biotech/Pharma, Business Development to me is a function that usually doesn’t have a lot of interaction with researchers unless they need data from you but the decisions they make influence researchers the most. ...Read more
TeYu Chen, Medicinal Chemist
By Yi-ying Chou on Nov, 2018
I always thought that doing biological experiments, like sitting long hours in front of tissue culture hood, can be physically challenging. When I chat with Ryan, I realized that medicinal chemists also have heavy workload on the bench side. In pharmaceutical company, chemists are not allowed to be ...Read more
2023 Symposium Sponsors
